Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Rotaxane synthesis via a dynamic [2]catenane-ring-opening, axle-cleaving double cross metathesis

M. Mustafa Cetin*afg, Arindam Mazumdarb, David B. Cordesc, Vahap Gazi Fidand, Zhen Yange and Michael F. Mayer*b
aDepartment of Chemistry, İstinye University, Sarıyer, İstanbul 34396, Türkiye. E-mail: mustafa.cetin@istinye.edu.tr; mustafamcetin@yahoo.com
bDepartment of Chemistry and Biochemistry, Texas Tech University, MS-41062, Lubbock, TX 79409, USA. E-mail: mf.mayer@ttu.edu
cEaStCHEM School of Chemistry, University of St. Andrews, St. Andrews, KY16 9ST, UK
dDepartment of Chemical and Biological Engineering, Koç University, Sarıyer, İstanbul 34450, Türkiye
eStrait Institute of Flexible Electronics (SIFE, Future Technologies), Fujian Key Laboratory of Flexible Electronics, Fujian Normal University and Strait Laboratory of Flexible Electronics (SLoFE), Fuzhou, 350117, China
fSynthetic Organic and Polymer Research (SOPR) Laboratory, İstinye University, Sarıyer, İstanbul 34396, Türkiye
gClean Energy Research Center (TEAM), İstinye University, Sarıyer, İstanbul 34396, Türkiye

Received 21st September 2025 , Accepted 12th November 2025

First published on 1st December 2025


Abstract

Efficient routes to [2]rotaxanes are often compromised by formation of irrecoverable, non-interlocked byproducts. Herein, we report a thermodynamically steered, atom-economical strategy that couples a Cu(I)-templated, low-strain Sauvage-type [2]catenane with di-stoppered olefin via ring-opening double cross-metathesis (RO-DCM), implementing dynamic covalent chemistry to bias the system toward the most stable interlocked architecture. The transformation proceeds through ring opening of the metalated [2]catenane and its in situ “insertion” into the axle, engaging internal olefins on both partners. Optimization of metathesis parameters (Grubbs II, DCM, 40 °C) identified the stoichiometry of the di-stoppered olefin as the key lever; using ten equivalents furnished the metalated [2]rotaxane 6 in up to 88% isolated yield while suppressing mono-stoppered byproducts. Subsequent demetalation cleanly delivered [2]rotaxane 9. Analytical size-exclusion chromatography across the full component set provided diagnostic retention times, confirming product identity and the absence of catenane contamination. No dethreading of macrocycle 1 from 9 was detected under conventional heating in DCM or DMSO over 12–48 hours, underscoring kinetic persistence of the mechanical bond. Overall, this RO-DCM platform minimizes non-interlocked waste streams while providing a concise, high-yield entry to [2]rotaxanes from metathesis-addressable, copper-templated interlocks. Beyond the single-molecule level, the approach establishes a general ring-chain equilibration blueprint that should translate to sequence-defined, mechanically interlocked oligomers and polymers.


Introduction

Apart from the aesthetic appeal, the intrinsically dynamic nature of mechanically-interlocked molecules (MIMs) makes them even more interesting. The nature of the mechanical bond between the two interlocked components such as rotaxanes and catenanes encodes programmable, stimulus-responsive motion in a mechanically-bonded architecture, making them archetypal building blocks for molecular machines. In these systems, a mechanical bond between components permits controlled, often reversible, relative motion in response to external stimuli such as redox conditions, pressure, pH, thermal changes, or applied mechanical force. Light can also trigger topology interconversion in MIMs as seen in the example of photodriven rotaxane to catenane transformation via reversible anthracene dimerization.1 This responsive mobility forms the foundation for molecular machines, which over the past four decades have evolved into sophisticated constructs including molecular shuttles,2–6 muscles,7–12 switches,13–15 and drug carriers.16–18

The underlying theme of chemical systems classifiable under the rubric of dynamic covalent chemistry (DCC) is that such systems allow a redistribution of covalent bonds between substructural components where net redistribution is tantamount to a thermodynamic re-equilibration under altered conditions. DCC involves reversible covalent bond formation and exchange, enabling adaptive, self-healing, and recyclable materials. The mechanistic rationale centers on the interplay between thermodynamics and kinetics, with bond exchange processes classified as associative or dissociative, and their behavior modulated by catalysts, temperature, and network structure. DCC mechanisms are typically divided into four mechanistic categories and molecular basis. (i) Associative (exchange without bond dissociation): the network maintains constant crosslinking density, as seen in vitrimers, where bond exchange occurs via a concerted pathway. This is rare; most systems involve some degree of bond dissociation.19,20 (ii) Dissociative (bond breaking precedes new bond formation): the network temporarily loses crosslinks, leading to changes in material properties.19–21 (iii) Thermodynamic control: product distribution is determined by the relative stability of products, not just reaction rates, and external stimuli (temperature, pH, catalysts) shift equilibrium, enabling reversible assembly/disassembly.21–23 (iv) Kinetic considerations: the rate of bond exchange, influenced by catalysts or additives, directly affects viscoelastic and mechanical properties.19,20,24 Thus, DCC plays a pivotal role in constructing such superior versatile molecular architectures through reversible covalent bond formation. Under thermodynamic control, DCC allows the reorganization of molecular subcomponents, enabling error correction and amplification of desired products, especially in the presence of guiding templates. This strategy in an unprecedented molecular precision manner offers significant advantages for generating functional systems. When thermodynamics and kinetics are compared, kinetics determines how quickly materials respond to stimuli, crucial for applications like 3D printing or self-healing while thermodynamics governs equilibrium.20–22 Dynamic covalent processes are governed by well-defined mechanistic categories—associative and dissociative exchange—modulated by thermodynamic and kinetic factors. Catalysts, network design, and external stimuli enable precise control over material properties,19,20,24–26 supporting the development of adaptive, recyclable, and self-healing polymers. Building on these DCC foundations, we harness thermodynamic control to orchestrate a reversible ring-chain equilibration in which a Cu(I)-templated, metathesis-addressable [2]catenane undergoes ring-opening double cross-metathesis (RO-DCM) with a di-stoppered axle, effecting in situ “insertion” and channeling the system toward the most stable [2]rotaxane while suppressing non-interlocked byproducts. In this way, the abstract DCC principles of error-correction and product amplification translate into a concise, atom-economical route to [2]rotaxanes and a general blueprint for sequence-defined interlocked polymers.

Among MIMs, rotaxanes27—molecules where a macrocycle is threaded onto a dumbbell-shaped axle and trapped by bulky stoppers—are central to the field of mechanically interlocked molecules and they occupy a unique position due to their modular architecture and wide functional versatility. Traditionally, their synthesis has relied on four main strategies: slipping, clipping, threading–capping, and the active template approach.28 While the thermodynamically-driven slipping method laid early groundwork, the kinetically-controlled clipping and threading–capping techniques have offered more reliable access to rotaxanes. However, these methods often suffer from the formation of irrecoverable non-interlocked byproducts, such as free macrocycles or stopper-functionalized axles, significantly limiting their efficiency and scalability. Rotaxane synthesis—active template synthesis,27,29–32 template-directed clipping,33 end-capping and swelling,34,35 stereoselective and enantioselective synthesis,29,36–41 functional and sequence-controlled rotaxanes,42–46 and many more—has evolved rapidly, with new strategies enabling greater control over structure, chirality, and function, opening doors to applications in molecular machines, catalysis, and materials science.27 Recent research has delivered a diverse toolkit for rotaxane synthesis, including highly selective, efficient, and versatile methods. Advances in chiral and sequence-controlled synthesis are enabling new applications in catalysis, materials, and molecular machinery, with ongoing innovation in both methodology and functional design.27

Rotaxanes as mechanically interlocked molecules with a macrocycle threaded onto an axle are foundational in supramolecular chemistry47 and have rapidly expanded into polymer science, materials chemistry, catalysis, sensing, and more. Their unique dynamic and switchable properties enable advanced functions in smart materials, electronics, catalysis, and molecular machines. They also have various key applications in the areas of supramolecular and polymer chemistry47–54 as smart and tough materials,47–49,54 stimuli-responsive systems,50–52 and preprogrammed assembly,53 sensing and optoelectronics47,55–57 as chemo-/biosensors47,55,56 and mechanoluminescent materials,57 catalysis and synthetic chemistry47,58,59 as catalytic platforms and superbases,59 molecular machines and advanced functions47,51,60,61 as molecular switches and machines,51,60,61 and many more. Thus, rotaxanes are enabling breakthroughs in supramolecular and polymer chemistry, with expanding roles in smart materials, sensing, catalysis, and molecular machines. Their dynamic, tunable properties continue to drive innovation across multiple scientific and technological domains.47

Recently, our approach to rotaxanes synthesis has utilized the concept of DCC which involves cleaving of the axle to allow pseudorotaxane formation followed by a subsequent thermodynamically-controlled transformation into a rotaxane. Aiming to achieve versatile MIMs, we unveiled a novel, viable thermodynamically-controlled synthesis of a metalated [2]rotaxane via the in situ “insertion” of a metalated [2]catenane into a di-stoppered axle (Scheme 1). In contrast to previous methods, this route occurs via a dynamic ring-chain equilibration of copper-chelated [2]catenane and an acyclic chain transfer agent by avoiding undesired dead-end byproducts, opening a new avenue to [2]rotaxanes. This newly developed strategy thus not only extends the synthetic methods for [2]rotaxanes but also brings a new insights into constructing previously inaccessible mechanically-interlocked polymers.


image file: d5ra07142a-s1.tif
Scheme 1 A novel, viable thermodynamically-controlled synthesis of a [2]rotaxane from metalated [2]rotaxane via dynamic ring-chain equilibration and then demetalation.

Results and discussion

Launching from the design logic of dynamic covalent chemistry, we conceived a thermodynamically governed ring-opening double cross-metathesis that inserts a metalated [2]catenane into a di-stoppered axle, thereby forging the target [2]rotaxane with minimal dead-end byproducts. Under equilibrium control, DCC enables error-correction and amplifies the most stable interlocked product, providing an ideal platform for such reversible bond choreography.62 Mechanistically, our strategy harnesses established ring-opening (cross) metathesis/cross metathesis (RO(C)M/CM) manifolds with Ru-carbene catalysts (Grubbs II/Hoveyda–Grubbs),63,64 which excel in ring opening and cross metathesis of internal olefins under mild conditions.65,66 The reverse transformation—conversion of a crown-ether-based active-template synthesis (CEATS) [2]rotaxane into a [2]catenane by ring-closing metathesis (RCM) under high-dilution conditions using Grubbs I—has also been studied by Barlow and Evans.67 A Sauvage-type Cu(I) catenane serves as a low-strain yet metathesis-addressable precursor, aligning with precedents on copper-templated interlocks and their reactivity.63,68–70 Together, these elements converge to deliver an atom-economic route to [2]rotaxanes while foreshadowing access to mechanically interlocked polymers that were previously out of reach.71

The transformation (Scheme 2) requires the simultaneous ring-opening of metalated [2]catenane 5, followed by its in situ “insertion” into di-stoppered axle 3. Notably, ring-opening of small to medium-sized olefinic rings, coupled in situ with terminal or internal olefinic substrates via ring-opening cross-metathesis, has been successfully demonstrated in prior studies.72–77 Building on this precedent, we envisioned that the internal olefin functionalities present on both 5 and 3 would enable a ring-opening double cross-metathesis to afford the desired [2]rotaxane 9 upon demetalation of 6.


image file: d5ra07142a-s2.tif
Scheme 2 Synthesis of (a) metalated [2]catenane 5, (b) di-stoppered olefin 3, (c) ring-opening double cross-metathesis of the di-stoppered olefin 3 and a metalated [2]catenane 5 to form metalated [2]rotaxane 6, and (d) [2]rotaxane 9 from metalated [2]rotaxane 6.

To this end, we selected a low-strain Sauvage-type [2]catenane63,69,70 as the substrate, which has been successfully demonstrated its ring-opening reactivity.78 The synthesis of 5 (Scheme 2a) was constructed from metalated [2]pseudorotaxane 4 via ring-closing metathesis in the presence of 5 mol% Grubbs' second-generation catalyst,64 furnishing the product in 73% yield. This catenane was tactfully designed with an internal olefin on the larger macrocycle to enable further transformations via metathesis. In addition, two methyl groups were introduced on the phenyl rings of the smaller macrocycle 1 as spectroscopic markers to confirm its presence in the final [2]rotaxane 6.

The di-stoppered olefin 3 was synthesized (Scheme 2b) in 78% yield via cross-metathesis of mono-stoppered olefin 2, using the same Grubbs catalyst,64 ethereal linkages were introduced adjacent to the internal olefin to enhance solubility. The resulting olefinic product was obtained as a mixture of E/Z isomers in an approximate 4[thin space (1/6-em)]:[thin space (1/6-em)]1 ratio across four experiments, and separation of these isomers by column chromatography proved unsuccessful. During optimization studies, we found that the cis-isomer was preferentially consumed in the metathesis reaction, as evidenced by comparative 1H NMR analysis of the starting and recovered 3 (Fig. 1). This observation suggested that enriching the cis-isomer content by increasing the equivalents of 3 could enhance the overall yield of the target metalated [2]rotaxane 6, as proved by increasing to ten equivalents of 3 leading to a yield of 88% (Table 1, entry 10).


image file: d5ra07142a-f1.tif
Fig. 1 Reaction depicted and diagnostic E/Z ratio for the optimized RO-DCM that converts metalated [2]catenane 5 and di-stoppered olefin 3 into metalated [2]rotaxane 6 (Table 1, entry 10). Shown are the 1H NMR spectra of 3 recorded before the reaction (E/Z = 4.51[thin space (1/6-em)]:[thin space (1/6-em)]1.00, left) and of recovered, unreacted 3 after the reaction (E/Z = 4.98[thin space (1/6-em)]:[thin space (1/6-em)]1.00, right). The modest increase in the E/Z ratio indicates preferential consumption of the Z isomer under the optimized metathesis conditions, consistent with the high yield of 6 obtained in this trial. Integration of the diagnostic vinyl resonances was used to determine E/Z (highlighted as trans and cis).
Table 1 Optimization studies of reaction conditiona
Entry Equiv. of 5 Equiv. of 3 Catalyst Temp. (°C) Time (h) Conc. (mM) Yield (6)b
a All reactions were carried out with one equiv. of 5 and 5 mol% of catalyst in dichloromethane except where noted. Equiv. of 3 was relative to the equiv. of 5.b Isolated yield.c G-II stands for Grubbs' second generation catalyst.d GH-II stands for Blechert/Hoveyda–Grubbs' second generation catalyst.63e Dichloroethane was used as solvent.
1 1 1 G-IIc Rt 12 10 7
2 1 1 G-II Rt 24 10 13
3 1 1 G-II 40 24 10 23
4 1 1 GH-IId 40 24 10 24
5 1 1 G-II 58e 24 10 25
6 1 1 G-II 40 24 1 11
7 1 1 G-II 40 24 50 26
8 1 2.5 G-II 40 24 10 73
9 1 5 G-II 40 24 10 81
10 1 10 G-II 40 24 10 88


Initial attempts to synthesize 6 (Scheme 2c) were carried out using equimolar amounts of 5 and 3 in 10 mM dichloromethane solution with 5 mol% Grubbs II64 under nitrogen atmosphere at room temperature for 12 hours. The product was isolated as a dark brown solid in 7% yield (Table 1, entry 1). No mono-stoppered byproducts were detected, although both unreacted starting materials (5 and 3) were recovered. Encouraged by this result, we optimized several parameters to improve the yield of the metalated 6 (Table 1).78–82

Extending the reaction time to 24 hours resulted in a nearly two-fold increase in yield (13%, Table 1, entry 2), but further extension to 48 hours provided no significant additional benefit. Investigating the effect of temperature revealed that increasing the reaction temperature improved the yield substantially (Table 1, entry 3). We also explored the use of Blechert/Hoveyda–Grubbs' second-generation catalyst63 due to its known efficacy in cross-metathesis. While it afforded the desired product 6, the yield (24%) did not surpass that achieved under optimal conditions with Grubbs' second-generation catalyst64 (Table 1, entry 4), which was thus selected for all subsequent reactions.

Solvent screening demonstrated that dichloromethane at reflux temperature was optimal for this transformation. Switching to dichloroethane (DCE) and raising the temperature further did not improve the yield (Table 1, entry 5). We then examined the effect of substrate concentration. Reducing the concentration of 5 to 1 mM (Table 1, entry 6) or increasing it to 50 mM (Table 1, entry 7) both led to suboptimal yields, establishing 10 mM as the ideal concentration. As anticipated, increasing the equivalents of 3 led to the enhanced yields (Table 1, entries 8–10), culminating in an 88% yield under optimized conditions.

The identity of 6 was confirmed via 1H NMR spectroscopy. Diagnostic signals included sharp aromatic peaks corresponding to the copper-complexed phenanthroline moieties and a singlet at δ 1.29 ppm, attributable to the tert-butyl groups of the stoppers. A singlet at δ 1.50 ppm for six methyl protons confirmed the incorporation of macrocycle 1 into the product. The olefinic region also displayed signals consistent with successful metathesis and stoppering. These spectroscopic features indicate that 6 was indeed formed through a ring-opening double cross-metathesis between 5 and 3, resulting in the symmetrical incorporation of the macrocycle within the di-stoppered axle.

Although the signal at δ 1.50 ppm indicated the presence of the methyl groups of 1 in the product, it was not clear if they were cis-, trans-, or mixture of both cis- and trans- to each other. In order to observe the relative positions of methyl groups, the core complex 7, which is a copper(I) complex of the 2,9-di(4-methoxyphenyl)-1,10-phenanthroline ligand and macrocycle 1, was synthesized81,82 (Scheme 3), purified, and crystallized. Dark red prismatic and plate-shaped single crystals of the core complex were grown by slow cooling and evaporation of a methanol solution. Single-crystal X-ray diffraction showed these to be two different polymorphs of the core complex. The solid-state structures of both polymorphs (Fig. 2, S33 and S34) comprise a single [2]pseudocatenane as well as a PF6 anion, they differ slightly in the coordination arrangement of the ligands about the Cu(I) center, and more so in the arrangement of the glycol chains (Fig. S35). The Cu–N bond lengths of the first polymorph are typical [2.018(9) to 2.059(8) Å] of such complexes, those of the second polymorph slightly longer [2.034(10) to 2.094 Å], and, although the N–Cu–N angles show significant distortion from ideal tetrahedral geometry [82.0(3) to 134.7(3)° and 83.5(4) to 135.9(4)° for polymorphs 1 and 2 (Fig. S33 and S34), respectively], this is in agreement with previously reported examples.83,84 These distortions enable a more compact geometric arrangement of the individual complexes, with a number of intramolecular π⋯π interaction taking place [centroid⋯centroid distances 3.680(6) to 3.919(5) Å and 3.707(8) to 3.968(8) Å for the two polymorphs]. Efficient packing of the complexes in both polymorphs is aided by weak hydrogen bonds between both aliphatic and aromatic hydrogens and methoxy and glycol oxygens, as well as fluorides of the PF6 anions (CH⋯acceptor distances 2.05 to 2.53, and 2.34 to 2.52 Å). Neither polymorph displayed intermolecular CH⋯π interactions, and only polymorph 2 showed any intermolecular π⋯π interactions, occurring between benzene rings of the two different ligands on adjacent molecules, at a centroid⋯centroid distance of 3.600(5) Å. It is perhaps surprising that only one methyl group, in polymorph 2, forms an intermolecular interaction with nearby aromatic systems, however, this is likely due to the benzene-ring systems they are bound to being oriented to take part in intramolecular π⋯π interactions.


image file: d5ra07142a-s3.tif
Scheme 3 Synthesis of core complex 7.

image file: d5ra07142a-f2.tif
Fig. 2 View of the solid state structure of polymorphs 1 (left) and 2 (right) of the core complex 7, hydrogen atoms, anions, and minor component of disorder were omitted for clarity, ellipsoids are drawn at the 50% probability level (Cu: orange, O: red, N: blue, C: light or dark gray).

The two methyl groups on macrocycle 1 allow for a few limiting stereoisomeric structures82 for the core complex 7. These groups may be oriented in the same(cis)/opposite(trans) or cis and trans directions, which allow a cis-, or trans-isomer or an isomer with methyl groups in cis and trans directions. However, the methyl groups in both polymorphic structures of 7 reveal a solid-state preference for a cis-isomer (Fig. 2, S33 and S34). Similarly, as it is mentioned in the literature,80 the presence of the methyl groups on the ligands of homoleptic copper(I) complexes of 2,9-di(4-methoxy-3-methylphenyl)-1,10-phenanthroline and 2,9-di(4-hydroxy-3-methylphenyl)-1,10-phenanthroline ligands also allows for numerous limiting stereoisomeric structures for the respective complexes.80,82 However, in the X-ray crystal structure of the copper(I) complex of 2,9-di(4-methoxy-3-methylphenyl)-1,10-phenanthroline ligand, the methyl groups were found to be a pair of enantiomeric trans, trans-atropisomers. Comparing 1H NMR spectra of the copper(I) complex of 2,9-di(4-methoxy-3-methylphenyl)-1,10-phenanthroline ligand and that of complex 7 (Fig. S21 and S22, S25–S28), neither complex showed splitting or multiple signals for the trans or cis methyls. Even in variable temperature (VT) 1H NMR studies (Fig. S23 and S24), no additional signals or even signal broadening resulting from the methyl protons in 7 were observed.

Following synthesis of the metalated [2]rotaxane 6 (Scheme 2c), demetalation (Scheme 2d) yielded [2]rotaxane 9. Its interlocked structure was confirmed via 1H NMR (Fig. S31) and analytical size-exclusion chromatography (SEC) (Fig. S44). Demetalation was achieved by treating 6 with aqueous KCN in acetonitrile–dichloromethane. After completion, ethyl vinyl ether (2 drops in 0.1–0.2 mL dichloromethane) was added, stirred for 5 min at room temperature. The disappearance of the dark brown color indicated demetalation. Solvents were evaporated to afford crude 9 (Scheme 2d), which was purified by preparative SEC and analyzed via analytical SEC (Fig. S44), which confirmed formation of [2]rotaxane 9. Retention times were 18.8, 18.3, 17.3, 17.6, 16.4, 17.8, and 16.6 min for macrocycle 1, mono-stoppered olefin 2, di-stoppered olefin 3, metalated [2]catenane 5, metalated [2]rotaxane 6, [2]catenane 8, and [2]rotaxane 9, respectively (Fig. 3a and b). [2]Catenane 8 exhibited a sharp peak with tailing at 17.8 min (Fig. 3b, black), while 5 showed a sharp peak at 17.6 min (Fig. 3b, green). In contrast, metalated [2]rotaxane 6 (Fig. 3b, brown) and [2]rotaxane 9 (Fig. 3b, blue) exhibited sharp peaks at 16.4 and 16.6 min, respectively. The absence of a 17.8 min peak confirmed no contamination of 9 with 8. To examine potential dethreading of macrocycle 1 from 9 upon demetalation, the conventional heating experiments42 were conducted in dichloromethane (30–40 °C) and dimethyl-sulfoxide (80–120 °C) for 12–48 h. No dethreading was detected.


image file: d5ra07142a-f3.tif
Fig. 3 Combined size-exclusion chromatograms of (a) macrocycle 1 (black), mono-stoppered olefin 2 (purple), di-stoppered olefin 3 (red), metalated [2]catenane 5 (green), metalated [2]rotaxane 6 (brown), and [2]rotaxane 9 (blue), and (b) metalated [2]catenane 5 (green), [2]catenane 8 (black) metalated [2]rotaxane 6 (brown), and [2]rotaxane 9 (blue).

Conclusion

In conclusion, we demonstrated a novel synthesis in which a thermodynamically steered ring-opening double cross-metathesis between a Cu(I)-templated [2]catenane 5 and a di-stoppered axle 3 delivered the target metalated [2]rotaxane 6 in high yield of 88% which was quantitatively converted to [2]rotaxane 9 via demetalation, while suppressing irrecoverable, non-interlocked byproducts. By exploiting dynamic covalent chemistry under equilibrium control, the system self-edits to the most stable interlocked architecture—circumventing inefficiencies that commonly afflict clipping/threading/slipping and related active-template routes.62,85 Mechanistically, the approach capitalizes on well-established Ru-carbene metathesis manifolds (RO(C)M/CM) that engage internal olefins under mild conditions,65,66 providing a robust and atom-economical bond-reorganization platform. The choice of a low-strain Sauvage-type catenane68,86 ensures metathesis addressability without sacrificing mechanical integrity, consistent with the copper-templated foundations of catenane chemistry. Spectroscopic and SEC analyses authenticate the interlocked product, and demetalation preserves the mechanical bond with no detectable dethreading under thermal stress—underscoring the kinetic persistence of the architecture. By contrast, coordination-driven, ligand-bound catenanes can be formed reversibly from rotaxanes (bis-Zn-porphyrin ‘tweezers’ + DABCO or 4,4′-bipyridine).87 Beyond furnishing a concise entry to [2]rotaxanes, the strategy establishes a general, dynamic ring-chain equilibration blueprint that is readily extendable to sequence-defined mechanically interlocked polymers and topologies previously deemed synthetically inaccessible.88,89 Thus, this methodology highlights the potential of metalated [2]rotaxane 6 as a versatile intermediate for constructing oligorotaxanes via partial depolymerization of polypseudorotaxanes derived from 5. Future efforts will explore the application of 6 in accessing oligo- and polyrotaxanes, expanding its utility in supramolecular polymer synthesis.

Experimental section

Experimental: general methods

Material and instrumentation. Anhydrous dichloromethane (DCM) and acetonitrile were separately distilled over CaH2 under nitrogen. Diethyl ether and tetrahydrofuran (THF) were separately distilled over Na/benzophenone under nitrogen. N,N-Dimethylformamide (DMF) was passed through FC 15 packed columns within a manual solvent purification system from MBraun. 2,9-Di(4-hydroxyphenyl)-1,10-phenanthroline and 2,9-di(4-methoxyphenyl)-1,10-phenanthroline,63 dialcohol,70 α,ω-diolefin,78 2,9-di(4-methoxy-3-methylphenyl)-1,10-phenanthroline and 2,9-di(4-hydroxy-3-methylphenyl)-1,10-phenanthroline,90 tris(p-tert-butylphenyl)methanol, 4-tris(p-tert-butylphenyl)phenol and mono-stoppered linear alcohol,91,92 10-bromo-1-decene,93,94 2-methylanisole,95 4-bromo-2-methylanisole,96 Grubbs' first generation catalyst for the synthesis of II,97,98 and Grubbs' second generation catalyst64 were prepared using literature procedures. 1H NMR and 13C NMR spectra were recorded on a Varian Mercury Plus 300 or a Varian Unity Inova 500 spectrometer. For 1H NMR spectra, tetramethylsilane (TMS, δ = 0.00) or the residual protic solvent peak (for CD2Cl2, δ = 5.32, for CDCl3, δ = 7.26, and for DMSO-d6, δ = 2.50) served as a shift reference. Coupling constants, J, are reported in hertz (Hz). For 13C NMR spectra which were obtained with 1H decoupling, CDCl3 (δ = 77.16), CD2Cl2 (δ = 53.84) and (CD3)2SO (δ = 39.52) were used as a shift reference. HMQC spectra were recorded on a Varian Unity Inova 500 spectrometer. High-resolution ESI mass spectrometry was performed on an Exactive-Orbitrap mass spectrometer at Texas Tech University (Lubbock, TX), and a Micromass Q-Tof Ultima spectrometer in the University of Illinois Mass Spectrometry Laboratories (Urbana-Champaign, IL). Elemental analyses were performed on a PerkinElmer 2400 Series II Elemental Analyzer at the Texas Tech University (Lubbock, TX), and by Columbia Analytical Service, Inc. (Tucson, AZ). Analytical size-exclusion chromatography (SEC) was performed on a system which consisted of a Dionex P680 pump and a Dionex UVD 170U/340U UV-Vis detector. Two Waters Styragel HR 4E (7.8 × 300 mm) columns were used in series and maintained at 24 °C. Chloroform (CHCl3) was used as the mobile phase at a flow rate of 1.0 mL min−1. Detection was performed at a wavelength of 254 or 313 nm. Molecular weights were estimated (by SEC) by calibration with monodisperse (PDI < 1.1) polystyrene standards, retention time (min)/Mw: 18.3/6.0 × 102, 18.0/1.0 × 103, 16.2/4.0 × 103, 14.2/2.0 × 104, 13.4/5.0 × 104, 12.6/1.0 × 105 (Polysciences, Inc.). Preparative SEC was performed using Bio-Beads® S-X1 Beads (200–400 mesh) with DCM (CH2Cl2) as eluent. Flash chromatography was performed using Silicycle UltraPure Flash Silica Gel (60 Å, 40–63 µm). Thin layer chromatography (TLC) was performed using EMD HPTLC plates, silica gel 60, F254. All reaction vessels were flame-dried under vacuum and filled with nitrogen prior to use. All reactions were performed under a nitrogen atmosphere as a routine practice, not as an essential requirement.

Synthetic procedures and structural determination data

The detailed synthetic procedures and structural characterization data for the intermediates and desired compounds are presented in the SI. Some important details and structural determination data for the intermediates and desired product(s) are presented below.
Dimethylated macrocycle 1. Obtained the dimethylated macrocycle 1 (12.5 g, 82%) as a bright yellow solid, m.p. 153.8–155.1 °C; 1H NMR (500 MHz, CDCl3) δ 8.37 (dd, 2.0, 2.0 Hz, 2H), 8.26–8.24 (m, 4H), 8.07 (d, J = 8.0 Hz, 2H), 7.74 (s, 2H), 7.15 (d, J = 8.5 Hz, 2H), 4.34 (t, J = 5.0 Hz, 5.5 Hz, 4H), 3.84 (t, J = 5.5 Hz, 5.0 Hz, 4H), 3.75–3.69 (m, 12H), 2.42 (s, 6H); 13C NMR (125 MHz, CDCl3) 158.37, 156.40, 145.88, 136.53, 132.35, 130.14, 127.64, 127.27, 126.51, 125.41, 119.04, 112.95, 71.02, 70.66, 70.56, 69.52, 68.28, 16.69; HRMS (ESI) calcd for C36H39N2O6 [M + H]+ m/z 595.2803, found m/z 595.2800; anal. calcd for C36H38N2O6: C, 72.71; H, 6.44; N, 4.71; found: C, 72.33; H, 6.51; N, 4.66.
Mono-stoppered olefin 2. Obtained the mono-stoppered olefin 2 (8.81 g, 79%) as a white solid, m.p. 151.4–152.3 °C; 1H NMR (500 MHz, CDCl3) δ 7.23 (d, J = 8.5 Hz, 6H), 7.07 (d, J = 8.5 Hz, 8H), 6.78 (d, J = 9.0 Hz, 2H), 5.85–5.76 (m, 1H), 5.03–4.93 (m, 2H), 4.11 (t, J = 4.5 Hz, 5.5 Hz, 2H), 3.85 (t, J = 5.0 Hz, 2H), 3.72–3.70 (m, 2H), 3.64–3.60 (m, 2H), 3.48 (t, J = 6.5 Hz, 7.0 Hz, 2H), 2.13–2.08 (m, 2H), 1.71–1.66 (m, 2H), 1.30 (s, 27H); 13C NMR (125 MHz, CDCl3) δ 156.56, 148.27, 144.12, 139.72, 138.27, 132.20, 130.71, 124.01, 114.69, 113.06, 70.82, 70.76, 70.15, 69.78, 67.22, 63.03, 34.28, 31.37, 30.22, 28.76; HRMS (ESI) calcd for C46H61O3 [M + H]+ m/z 661.4615, found m/z 661.4618; anal. calcd for C46H60O3: C, 83.59; H, 9.15; found: C, 83.61; H, 8.85.
Di-stoppered olefin 3. Obtained the di-stoppered olefin 3 (mixture of cis- and trans-) as a white solid (121.5 mg, 78%), m.p. 165.9–168.8 °C; 1H NMR (500 MHz, CDCl3) δ 7.23 (d, J = 8.5 Hz, 12H), 7.08 (d, J = 8.5 Hz, 16H), 6.77 (d, J = 9.0 Hz, 4H), 5.50–5.35 (m, 2H), 4.11 (t, J = 5.0 Hz, 4H), 3.85 (t, J = 5.0 Hz, 4H), 3.72–3.70 (m, 4H), 3.62–3.59 (m, 4H), 3.49–3.44 (m, 4H), 2.11–2.02 (m, 4H), 1.67–1.61 (m, 4H), 1.30 (s, 54H); 13C NMR (125 MHz, CDCl3) δ 156.56, 148.27, 144.12, 139.70, 132.19, 130.71(trans), 130.01(cis), 124.01, 114.69, 113.05, 70.85, 70.80, 70.13, 69.79, 67.20, 63.03, 34.27, 31.37, 29.41, 28.99; HRMS (ESI) calcd for C90H116NaO6 [M + Na]+ m/z 1315.8664, found m/z 1315.8628; anal. calcd for C90H116O6: C, 83.54; H, 9.04; found: C, 83.32; H, 9.09.
Metalated [2]pseudorotaxane 4. Obtained the metalated [2]pseudorotaxane 4 as a red glassy solid (647 mg, 98%). 1H NMR (500 MHz, CDCl3) δ 8.63 (d, J = 8.5 Hz, 2H), 8.47 (d, J = 8.5 Hz, 2H), 8.20 (s, 2H), 8.02 (s, 2H), 7.86 (d, J = 8.5 Hz, 2H), 7.78 (d, J = 8.5 Hz, 2H), 7.47 (d, J = 8.0 Hz, 4H), 7.15 (d, J = 8.0 Hz, 2H), 6.95 (s, 2H), 6.08 (d, J = 8.5 Hz, 4H), 5.81 (d, J = 8.5 Hz, 2H), 5.79–5.72 (m, 2H), 4.96–4.87 (m, 4H), 3.86 (s, 4H), 3.78 (s, 8H), 3.74–3.70 (m, 8H), 3.65–3.62 (m, 12H), 3.59–3.57 (m, 4H), 3.48 (t, J = 7.0 Hz, 4H), 2.01–1.97 (m, 4H), 1.62–1.57 (m, 4H), 1.48 (s, 6H), 1.38–1.21 (m, 20H); 13C NMR (125 MHz, CDCl3) δ 159.26, 156.98, 156.70, 155.46, 143.20, 143.18, 139.05, 137.58, 136.76, 132.00, 131.06, 130.04, 128.96, 127.91, 127.65, 126.94, 126.30, 126.04, 125.62, 123.90, 123.84, 114.02, 112.90, 109.18, 71.46, 71.02, 70.77, 70.77, 70.69, 69.99, 69.33, 69.25, 67.35, 67.26, 33.65, 29.56, 29.31, 29.31, 28.94, 28.77, 25.98, 15.59; HRMS (ESI) calcd for C88H106CuN4O12 [M − PF6]+ m/z 1473.7098, found m/z 1473.7084; anal. calcd for C88H106CuF6N4O12P: C, 65.23; H, 6.59; N, 3.46; found: C, 64.86; H, 6.36; N, 3.38.
Metalated [2]catenane 5. Obtained the metalated [2]catenane 5 as a red glassy solid (358.7 mg, 73%). 1H NMR (500 MHz, CDCl3) δ 8.64 (d, J = 8.5 Hz, 2H), 8.48 (d, J = 8.0 Hz, 2H), 8.22 (s, 2H), 8.05 (s, 2H), 7.88 (d, J = 8.0 Hz, 2H), 7.80 (d, J = 8.0 Hz, 2H), 7.48 (d, J = 8.0 Hz, 4H), 7.18 (d, J = 8.0 Hz, 2H), 6.97 (s, 2H), 6.09 (d, J = 8.5 Hz, 4H), 5.83 (d, J = 8.5 Hz, 2H), 5.37–5.30 (m, 2H) (trans- and cis-), 3.88 (s, 4H), 3.78 (s, 8H), 3.75–3.73 (m, 8H), 3.71–3.69 (m, 4H), 3.66–3.65 (m, 8H), 3.61–3.59 (m, 4H), 3.54 (t, 4H), 1.98–1.90 (m, 4H), 1.67–1.62 (m, 4H), 1.50 (s, 6H), 1.38–1.25 (m, 20H); 13C NMR (125 MHz, CDCl3) δ 159.47, 157.24, 156.96, 155.77, 143.49, 143.47, 137.85, 137.04, 132.26, 131.39, 130.57 (trans), 130.33, 130.06 (cis), 129.25, 128.18, 127.95, 127.20, 126.61, 126.41, 125.87, 124.18, 124.12, 113.12, 109.43, 71.77, 71.31, 71.08, 71.05, 71.05, 70.43, 69.65, 69.54, 67.57, 67.57, 32.46, 29.80, 29.41, 29.40, 29.38, 28.71, 26.19, 15.88; HRMS (ESI) calcd for C86H102CuN4O12 [M − PF6]+ m/z 1445.6785, found m/z 1445.6782; anal. calcd for C86H102CuF6N4O12P: C, 64.87; H, 6.46; N, 3.52; found: C, 64.63; H, 6.17; N, 3.38.
Metalated [2]rotaxane 6. Obtained the metalated [2]rotaxane 6 as a dark brown solid (48.1 mg, 88%). 1H NMR (400 MHz, CDCl3) δ 8.64 (d, J = 8.2 Hz, 2H), 8.47 (d, J = 8.2 Hz, 2H), 8.22 (s, 2H), 8.02 (s, 2H), 7.88 (d, J = 8.2 Hz, 2H), 7.80 (d, J = 8.2 Hz, 2H), 7.48 (d, J = 8.7 Hz, 4H), 7.23–7.15 (m, 14H), 7.07 (d, J = 8.7 Hz, 16H), 6.96 (s, 2H), 6.77 (d, J = 8.7 Hz, 4H), 6.10 (d, J = 8.7 Hz, 4H), 5.82 (d, J = 8.2 Hz, 2H), 5.46–5.31 (m, 4H), 4.10 (t, J = 4.6 Hz, 4H), 3.88–3.43 (m, 56H), 2.04–1.74 (m, 8H), 1.69–1.59 (m, 8H), 1.50 (s, 6H), 1.38–1.26 (m, 74H); 13C NMR (100 MHz, CDCl3) δ 159.49, 157.18, 156.96, 156.68, 155.74, 148.41, 144.26, 143.46, 139.85, 137.77, 137.01, 132.34, 132.34, 132.27, 131.30, 131.05, 131.00, 130.90, 130.84, 130.84 (trans), 130.30 (cis), 129.55, 129.20, 128.14, 127.88, 127.15, 126.58, 126.28, 125.82, 124.16, 124.16, 113.18, 109.30, 71.78, 71.29, 71.04, 71.04, 70.94, 70.94, 70.22, 70.21, 69.91, 69.57, 69.56, 67.51, 67.50, 67.32, 63.16, 34.43, 32.72, 31.52, 31.52, 29.81, 29.80, 29.73, 29.62, 29.61, 29.29, 29.15, 26.25, 15.89; HRMS (MALDI) calcd for C176H219CuN4O18 [M + H-PF6]+ m/z 2739.5630, found m/z 2739.5598; anal. calcd for C176H218CuF6N4O18P: C, 73.24; H, 7.61; N, 1.94; found: C, 73.57; H, 7.24; N, 1.99.
Core complex 7. Obtained the core complex 7 (400 mg, 98%) as a red glassy solid, m.p. 252.4–253.0 °C; 1H NMR (500 MHz, CDCl3) δ 8.64 (d, J = 8.5 Hz, 2H), 8.46 (d, J = 8.0 Hz, 2H), 8.22 (s, 2H), 8.00 (s, 2H), 7.89 (d, J = 8.0 Hz, 2H), 7.80 (d, J = 8.0 Hz, 2H), 7.51 (d, J = 8.5 Hz, 4H), 7.18 (d, J = 8.5 Hz, 2H), 6.95 (s, 2H), 6.08 (d, J = 8.5 Hz, 4H), 5.81 (d, J = 8.0 Hz, 2H), 3.88 (s, 4H), 3.76–3.74 (m, 4H), 3.67–3.64 (m, 8H), 3.61–3.59 (m, 4H), 3.52 (s, 6H), 1.51 (s, 6H); 13C NMR (125 MHz, CDCl3) δ 160.28, 157.24, 157.06, 155.74, 143.46, 137.81, 136.86, 132.22, 131.20, 130.30, 129.28, 129.28, 128.16, 127.84, 127.20, 126.56, 126.09, 125.85, 124.19, 112.58, 112.58, 109.38, 71.31, 71.06, 71.06, 69.52, 67.52, 55.38, 15.88 ; HRMS (ESI) calcd for C62H58CuN4O8 [M − PF6]+ m/z 1049.3545, found m/z 1049.3521; anal. calcd for C62H58CuF6N4O8P: C, 62.28; H, 4.89; N, 4.69; found: C, 62.35; H, 4.69; N, 4.62.
Demetalated [2]catenane 8. Obtained the demetalated [2]catenane 8 which was further analyzed by analytical SEC; 1H NMR (400 MHz, CDCl3) δ 8.97 (dd, J = 2.3 Hz, 2H), 8.42 (d, J = 8.7 Hz, 4H), 8.24 (d, J = 8.3 Hz, 2H), 8.19 (d, J = 8.7 Hz, 2H), 8.08 (s, 2H), 8.06 (s, 2H), 7.77 (s, 2H), 7.71 (d, J = 10.1 Hz, 4H), 7.25–7.17 (m, 6H), 5.41–5.34 (m, 2H) (trans- and cis-), 4.28–4.26 (m, 4H), 4.20–4.17 (m, 4H), 3.97–3.90 (m, 4H), 3.77–3.67 (m, 20H), 3.59–3.53 (m, 4H), 3.39–3.34 (m, 4H), 2.27 (s, 6H), 2.01–1.96 (m, 4H), 1.51–1.48 (m, 4H), 1.31–1.23 (m, 20H); 13C NMR (100 MHz, CDCl3) δ 160.27, 158.21, 156.47, 156.47, 146.30, 146.10, 136.70, 136.50, 132.10, 132.03, 130.53 (trans), 130.05 (cis), 129.10, 129.10, 128.77, 128.28, 127.53, 127.37, 126.02, 125.60, 125.46, 119.44, 119.06, 115.25, 112.95, 71.58, 71.12, 71.00, 70.89, 70.63, 70.30, 70.06, 68.50, 67.72, 66.22, 32.61, 29.71, 29.55, 29.44, 29.32, 28.97, 26.18, 16.63; HRMS (ESI) calcd for C86H102N4O12 [M + H]+ m/z 1382.7489, found m/z 1382.7393.
Demetalated [2]rotaxane 9. Obtained the demetalated [2]rotaxane 9 which was further analyzed by analytical SEC; 1H NMR (400 MHz, CDCl3) δ 8.92 (d, J = 8.7 Hz, 2H), 8.40 (d, J = 8.2 Hz, 4H), 8.21 (d, J = 8.2 Hz, 4H), 8.07–8.03 (m, 4H), 7.75 (s, 2H), 7.70 (s, 4H), 7.23–7.15 (m, 18H), 7.06 (d, J = 8.7 Hz, 16H), 6.83–6.75 (m, 4H), 5.38–5.25 (m, 4H), 4.27–3.35 (m, 60H), 2.27 (s, 6H), 2.04–1.89 (m, 8H), 1.68–1.44 (m, 8H), 1.37–1.25 (m, 74H); 13C NMR (100 MHz, CDCl3) δ 160.27, 158.22, 156.73, 156.50, 148.35, 148.35, 146.15, 144.31, 139.74, 136.82, 136.50, 132.33, 130.85, 130.85 (trans), 129.56, 129.11 (cis), 128.78, 128.77, 128.75, 128.24, 128.21, 128.19, 127.62, 127.40, 125.67, 125.49, 124.15, 124.15, 119.49, 115.16, 113.38, 113.16, 112.96, 71.72, 71.02, 71.02, 70.90, 70.82, 70.58, 70.24, 70.24, 69.98, 69.96, 68.48, 67.69, 67.39, 66.27, 63.18, 34.42, 34.41, 32.75, 32.07, 31.51, 29.85, 29.80, 29.63, 29.76, 26.24, 22.85, 16.67, 14.28; HRMS (MALDI) calcd for C176H219N4O18 [M + H]+ m/z 2376.6339, found m/z 2376.3344.

Author contributions

This manuscript and its associated materials were prepared as follows: experimental design was conducted by M. M. C., M. F. M., and A. M.; chemical synthesis was performed by M. M. C.; manuscript drafting was carried out by M. M. C. and M. F. M.; spectral data analysis was performed by M. M. C. and M. F. M.; crystallographic studies and structural analysis were undertaken by D. B. C. and M. M. C.; reviewing and editing were completed by M. M. C., M. F. M., D. B. C., Z. Y. and V. G. F.; visual content creation (images, figures, and graphical abstract) was handled by V. G. F. and M. M. C.; additional supporting details were prepared by M. M. C. All data were generated in-house, and no paper mill was used. All authors agree to be accountable for all aspects of work ensuring integrity and accuracy.

Conflicts of interest

The authors declare no competing financial interest or personal relationships that may have affected their work.

Data availability

CCDC 967317 and 2469972 (polymorphs (1 and 2) of the core complex 7) contain the supplementary crystallographic data for this paper.99a,b

The data supporting this article have been included as part of the supplementary information (SI). Supplementary information: synthetic procedures and structural characterization data for the intermediates and desired compounds. See DOI: https://doi.org/10.1039/d5ra07142a.

Acknowledgements

The author (M. M. C.) thanks to Professor Sir Fraser Stoddart for his endless support in the discussion of the obtained results, insightful criticism and discussion, and patient encouragement during this work. Thus, this paper is dedicated to Professor Sir Fraser Stoddart. Financial support from the National Science Foundation (MFM research grant CHE-0847736 and NMR instrument grant CHE-1048553) is gratefully acknowledged. We thank Prof. Mechref and Dr Surowiec for HRMS data and CHN analysis. We also thank the Department of Chemistry and Biochemistry of Texas Tech University and Istinye University for use of the instrumental and/or computer facilities. Finally, the author greatly thanks to his wife Mine and sons Metehan Arda and Mert Kaan for willingly giving him time to complete this work.

References

  1. A. Tron, H.-P. Jacquot de Rouville, A. Ducrot, J. H. R. Tucker, M. Baroncini, A. Credi and N. D. McClenaghan, Chem. Commun., 2015, 51, 2810–2813 RSC .
  2. P. L. Anelli, N. Spencer and J. F. Stoddart, J. Am. Chem. Soc., 1991, 113, 5131–5133 CrossRef CAS PubMed .
  3. R. A. Bissell, E. Córdova, A. E. Kaifer and J. F. Stoddart, Nature, 1994, 369, 133–137 CrossRef CAS .
  4. S. Silvi, M. Venturi and A. Credi, J. Mater. Chem., 2009, 19, 2279–2294 Search PubMed .
  5. S. Chen, Y. Wang, T. Nie, C. Bao, C. Wang, T. Xu, Q. Lin, D. H. Qu, X. Gong, Y. Yang, L. Zhu and H. Tian, J. Am. Chem. Soc., 2018, 140, 17992–17998 CrossRef CAS PubMed .
  6. B. Yao, H. Sun, L. Yang, S. Wang and X. Liu, Front. Chem., 2021, 9, 832735 CrossRef CAS PubMed .
  7. T. R. Kelly, H. De Silva and R. A. Silva, Nature, 1999, 401, 150–152 CrossRef CAS PubMed .
  8. J. Berná, D. A. Leigh, M. Lubomska, S. M. Mendoza, E. M. Pérez, P. Rudolf, G. Teobaldi and F. Zerbetto, Nat. Mater., 2005, 4, 704–710 CrossRef PubMed .
  9. Y. Liu, A. H. Flood, P. A. Bonvallet, S. A. Vignon, B. H. Northrop, H.-R. Tseng, J. O. Jeppesen, T. J. Huang, B. Brough, M. Baller, S. Magonov, S. D. Solares, W. A. Goddard, C.-M. Ho and J. F. Stoddart, J. Am. Chem. Soc., 2005, 127, 9745–9759 CrossRef CAS PubMed .
  10. Q. Li, G. Fuks, E. Moulin, M. Maaloum, M. Rawiso, I. Kulic, J. T. Foy and N. Giuseppone, Nat. Nanotechnol., 2015, 10, 161–165 CrossRef CAS PubMed .
  11. J. Chen, F. K.-C. Leung, M. C. A. Stuart, T. Kajitani, T. Fukushima, E. van der Giessen and B. L. Feringa, Nat. Chem., 2018, 10, 132–138 CrossRef CAS PubMed .
  12. Q. Zhang, S.-J. Rao, T. Xie, X. Li, T.-Y. Xu, D.-W. Li, D.-H. Qu, Y.-T. Long and H. Tian, Chem, 2018, 4, 2670–2684 CAS .
  13. J. E. Green, J. Wook Choi, A. Boukai, Y. Bunimovich, E. Johnston-Halperin, E. DeIonno, Y. Luo, B. A. Sheriff, K. Xu, Y. Shik Shin, H.-R. Tseng, J. F. Stoddart and J. R. Heath, Nature, 2007, 445, 414–417 CrossRef CAS PubMed .
  14. G. Bottari, D. A. Leigh and E. M. Pérez, J. Am. Chem. Soc., 2003, 125, 13360–13361 CrossRef CAS PubMed .
  15. D. Dattler, G. Fuks, J. Heiser, E. Moulin, A. Perrot, X. Yao and N. Giuseppone, Chem. Rev., 2020, 120, 310–433 CrossRef CAS PubMed .
  16. T. D. Nguyen, Y. Liu, S. Saha, K. C. F. Leung, J. F. Stoddart and J. I. Zink, J. Am. Chem. Soc., 2007, 129, 626–634 CrossRef CAS PubMed .
  17. T. D. Nguyen, K. C. F. Leung, M. Liong, C. D. Pentecost, J. F. Stoddart and J. I. Zink, Org. Lett., 2006, 8, 3363–3366 CrossRef CAS PubMed .
  18. P. Trucillo, Processes, 2021, 9, 470 CrossRef CAS .
  19. J. M. Winne, L. Leibler and F. E. Du Prez, Polym. Chem., 2019, 10, 6091–6108 RSC .
  20. F. Van Lijsebetten, K. De Bruycker, E. Van Ruymbeke, J. M. Winne and F. E. Du Prez, Chem. Sci., 2022, 13, 12865–12875 RSC .
  21. S. Roh, Y. Nam, M. T. Nguyen, J.-H. Han and J. S. Lee, Molecules, 2024, 29, 3261 CrossRef CAS PubMed .
  22. J. Hu, S. K. Gupta, J. Ozdemir and H. Beyzavi, ACS Appl. Nano Mater., 2020, 3, 6239–6269 CrossRef CAS PubMed .
  23. S. Ulrich, Acc. Chem. Res., 2019, 52, 510–519 CrossRef CAS PubMed .
  24. F. Van Lijsebetten, J. O. Holloway, J. M. Winne and F. E. Du Prez, Chem. Soc. Rev., 2020, 49, 8425–8438 RSC .
  25. S. Huang, X. Kong, Y. Xiong, X. Zhang, H. Chen, W. Jiang, Y. Niu, W. Xu and C. Ren, Eur. Polym. J., 2020, 141, 110094 CrossRef CAS .
  26. B. Marco-Dufort, R. Iten and M. W. Tibbitt, J. Am. Chem. Soc., 2020, 142, 15371–15385 CrossRef CAS PubMed .
  27. Y. Xu, R. Kaur, B. Wang, M. B. Minameyer, S. Gsänger, B. Meyer, T. Drewello, D. M. Guldi and M. von Delius, J. Am. Chem. Soc., 2018, 140, 13413–13420 CrossRef CAS PubMed .
  28. D. B. Amabilino and J. F. Stoddart, Chem. Rev., 1995, 95, 2725–2828 CrossRef CAS .
  29. C. Tian, S. D. P. Fielden, B. Pérez-Saavedra, I. J. Vitorica-Yrezabal and D. A. Leigh, J. Am. Chem. Soc., 2020, 142, 9803–9808 CrossRef CAS PubMed .
  30. S. D. P. Fielden, D. A. Leigh, C. T. McTernan, B. Pérez-Saavedra and I. J. Vitorica-Yrezabal, J. Am. Chem. Soc., 2018, 140, 6049–6052 CrossRef CAS PubMed .
  31. T. Kurita, M. Higashi, J. Gimenez-Dejoz, S. Fujita, H. Uji, H. Sato and K. Numata, Biomacromolecules, 2024, 25, 3661–3670 CrossRef CAS PubMed .
  32. S. D. P. Fielden, ChemSystemsChem, 2024, 6, e202300048 Search PubMed .
  33. J. Wu, K. C.-F. Leung and J. F. Stoddart, Proc. Natl. Acad. Sci., 2007, 104, 17266–17271 CrossRef CAS PubMed .
  34. C.-W. Chiu, C.-C. Lai and S.-H. Chiu, J. Am. Chem. Soc., 2007, 129, 3500–3501 CrossRef CAS PubMed .
  35. K. Fujimura, Y. Ueda, Y. Yamaoka, K. Takasu and T. Kawabata, Angew. Chem., Int. Ed., 2023, 62, e202303078 CrossRef CAS PubMed .
  36. A. Imayoshi, B. V. Lakshmi, Y. Ueda, T. Yoshimura, A. Matayoshi, T. Furuta and T. Kawabata, Nat. Commun., 2021, 12, 404 CrossRef CAS PubMed .
  37. A. de Juan, D. Lozano, A. W. Heard, M. A. Jinks, J. M. Suarez, G. J. Tizzard and S. M. Goldup, Nat. Chem., 2022, 14, 179–187 CrossRef CAS PubMed .
  38. S. Zhang, A. Rodríguez-Rubio, A. Saady, G. J. Tizzard and S. M. Goldup, Chem, 2023, 9, 1195–1207 CAS .
  39. H. Yang, H.-X. Feng, J. Chen and L. Zhou, Chem.–Eur. J., 2025, 31, e202500898 CrossRef CAS PubMed .
  40. K. Wada, K. Yasuzawa, S. Fa, Y. Nagata, K. Kato, S. Ohtani and T. Ogoshi, J. Am. Chem. Soc., 2023, 145, 15324–15330 CrossRef CAS PubMed .
  41. N. Pairault, A. Bessaguet, R. Barat, L. Frédéric, G. Pieters, J. Crassous, I. Opalinski and S. Papot, Chem. Sci., 2021, 12, 2521–2526 RSC .
  42. J. E. M. Lewis, J. Winn, L. Cera and S. M. Goldup, J. Am. Chem. Soc., 2016, 138, 16329–16336 CrossRef CAS .
  43. H. Han, J. S. W. Seale, L. Feng, Y. Qiu and J. F. Stoddart, J. Polym. Sci., 2023, 61, 881–902 CrossRef CAS .
  44. C. K. Lee, Y. Feng, M. Tajik, J. P. Violi, W. A. Donald, J. F. Stoddart and D. J. Kim, J. Am. Chem. Soc., 2024, 146, 27109–27116 CrossRef CAS PubMed .
  45. D. R. McCarthy, K. Xu, M. E. Schenkelberg, N. A. N. Balegamire, H. Liang, S. A. Bellino, J. Li and S. T. Schneebeli, Chem. Sci., 2024, 15, 4860–4870 RSC .
  46. S. S. Razi, M. Marin-Luna, M. Alajarin, A. Martinez-Cuezva and J. Berna, Commun. Chem., 2024, 7, 170 CrossRef CAS PubMed .
  47. D. Aoki and T. Takata, Polymer, 2017, 128, 276–296 CrossRef CAS .
  48. R. Du, T. Bao, D. Kong, Q. Zhang and X. Jia, ChemPlusChem, 2024, 89, e202300706 CrossRef CAS .
  49. S. Ghiassinejad, M. Ahmadi, E. van Ruymbeke and C.-A. Fustin, Prog. Polym. Sci., 2024, 155, 101854 CrossRef CAS .
  50. S. Dong, J. Yuan and F. Huang, Chem. Sci., 2014, 5, 247–252 RSC .
  51. O. Borodin, Y. Shchukin, C. C. Robertson, S. Richter and M. von Delius, J. Am. Chem. Soc., 2021, 143, 16448–16457 CrossRef CAS PubMed .
  52. Z.-Q. Cao, Y.-C. Wang, A.-H. Zou, G. London, Q. Zhang, C. Gao and D.-H. Qu, Chem. Commun., 2017, 53, 8683–8686 RSC .
  53. G. Washino, M. A. Soto, S. Wolff and M. J. MacLachlan, Commun. Chem., 2022, 5, 155 CrossRef CAS PubMed .
  54. L. He, J. Wie, Z. Zhang, N. Shentu, J. Wang, J. Yu, Z. Ren, J. Liu, G. Li, F. Huang and S. Li, Macromolecules, 2024, 57, 7777–7786 CAS .
  55. F.-C. Ho, Y.-J. Huang, C.-C. Wie, C.-H. Wu, Y.-K. Li, J. I. Wu and H.-C. Lin, ACS Appl. Mater. Interfaces, 2020, 12, 53257–53273 CrossRef CAS PubMed .
  56. C. Gouda, B.-N. Pham, P. Q. Nhien, T. T. K. Cuc, C.-C. Wie, C.-H. Wu, J. I. Wu, Y.-K. Li and H.-C. Lin, Dyes Pigm., 2023, 208, 110873 CrossRef .
  57. Y. Sagara, M. Karman, A. Seki, M. Pannipara, N. Tamaoki and C. Weder, ACS Cent. Sci., 2019, 5, 874–881 CrossRef CAS PubMed .
  58. H. Guo, J. Ye, Z. Zhang, Y. Wang, X. Yuan, C. Ou, Y. Ding, C. Yan, J. Wang and Y. Yao, Inorg. Chem., 2020, 59, 11915–11919 CrossRef CAS PubMed .
  59. M. J. Power, D. T. J. Morris, I. J. Vitorica-Yrezabal and D. A. Leigh, J. Am. Chem. Soc., 2023, 145, 8593–8599 CrossRef CAS PubMed .
  60. S. Rashid, Y. Yoshigoe and S. Saito, RSC Adv., 2022, 12, 11318–11344 RSC .
  61. J.-X. Liu, K. Chen and C. Redshaw, Chem. Soc. Rev., 2023, 52, 1428–1455 RSC .
  62. S. J. Rowan, S. J. Cantrill, G. R. L. Cousins, J. K. M. Sanders and J. F. Stoddart, Angew. Chem., Int. Ed., 2002, 41, 898–952 CrossRef .
  63. C. Dietrich-Buchecker and J.-P. Sauvage, Tetrahedron, 1990, 46, 503–512 CrossRef CAS .
  64. M. Scholl, S. Ding, C. W. Lee and R. H. Grubbs, Org. Lett., 1999, 1, 953–956 CrossRef CAS PubMed .
  65. A. H. Hoveyda, J. Org. Chem., 2014, 79, 4763–4792 CrossRef CAS PubMed .
  66. M. R. Swart, C. Marais and E. Erasmus, ACS Omega, 2021, 6, 28642–28653 CrossRef CAS PubMed .
  67. S. R. Barlow and N. H. Evans, Org. Biomol. Chem., 2024, 22, 7632–7636 RSC .
  68. G. Gil-Ramírez, D. A. Leigh and A. J. Stephens, Angew. Chem., Int. Ed., 2015, 54, 6110–6150 CrossRef PubMed .
  69. B. Mohr, J.-P. Sauvage, R. H. Grubbs and M. Weck, Angew Chem. Int. Ed. Engl., 1997, 36, 1308–1310 CrossRef CAS .
  70. M. Weck, B. Mohr, J.-P. Sauvage and R. H. Grubbs, J. Org. Chem., 1999, 64, 5463–5471 CrossRef CAS PubMed .
  71. J. Yu, M. Gaedke and F. Schaufelberger, Eur. J. Org Chem., 2023, 26, e202201130 CrossRef CAS .
  72. M. L. Randall, J. A. Tallarico and M. L. Snapper, J. Am. Chem. Soc., 1995, 117, 9610–9611 CrossRef CAS .
  73. J. P. Morgan, C. Morrill and R. H. Grubbs, Org. Lett., 2002, 4, 67–70 CrossRef CAS PubMed .
  74. M. L. Macnaughtan, J. B. Gary, D. L. Gerlach, M. J. A. Johnson and J. W. Kampf, Organometallics, 2009, 28, 2880–2887 CrossRef CAS .
  75. Y. Zhu, J. Jia, X. Song, C. Gong and Y. Xia, Chem. Sci., 2024, 15, 13800–13806 RSC .
  76. I. Mandal and A. F. M. Kilbinger, Angew. Chem., Int. Ed., 2024, 63, e202409781 CrossRef CAS PubMed .
  77. F. A. Starvaggi, B. A. Suslick and Y. Xia, ACS Macro Lett., 2024, 13, 296–301 CrossRef CAS PubMed .
  78. S. Kang, B. M. Berkshire, Z. Xue, M. Gupta, C. Layode, P. A. May and M. F. Mayer, J. Am. Chem. Soc., 2008, 130, 15246–15247 CrossRef CAS PubMed .
  79. M. M. Cetin, S. Shafiei-Haghighi, J. Chen, S. Zhang, A. C. Miller, D. K. Unruh, D. J. Casadonte Jr, T. L. Lohr, T. J. Marks, M. F. Mayer, J. F. Stoddart and M. Findlater, J. Polym. Sci., 2020, 58, 1130–1143 CrossRef CAS .
  80. M. M. Cetin, R. T. Hodson, C. R. Hart, D. B. Cordes, M. Findlater, D. J. Casadonte Jr, A. F. Cozzolino and M. F. Mayer, Dalton Trans., 2017, 46, 6553–6569 RSC .
  81. M. M. Cetin, W. Peng, D. Unruh, M. F. Mayer, Y. Mechref and K. Yelekci, Front. Pharmacol, 2022, 13, 980479 CrossRef CAS PubMed .
  82. M. M. Cetin, PhD thesis, Texas Tech University, 2017 .
  83. J. E. Beves, B. A. Blight, C. J. Campbell, D. A. Leigh and R. T. McBurney, Angew. Chem., Int. Ed., 2011, 50, 9260–9327 CrossRef CAS PubMed .
  84. X. Mo, Y. Deng, S. K.-M. Lai, X. Gao, H.-L. Yu, K.-H. Low, Z. Guo, H.-L. Wu, H. Y. Au-Yeung and E. C. M. Tse, J. Am. Chem. Soc., 2023, 145, 6087–6099 CrossRef CAS .
  85. C. C. Anghel, T. A. Cucuiet, N. D. Hădade and I. Grosu, Beilstein J. Org. Chem., 2023, 19, 1776–1784 CrossRef CAS PubMed .
  86. J.-P. Sauvage, Angew. Chem., Int. Ed., 2017, 56, 11080–11093 CrossRef CAS PubMed .
  87. D. I. Schuster, K. Li, D. M. Guldi and J. Ramey, Org. Lett., 2004, 6, 1919–1922 CrossRef CAS PubMed .
  88. F. Sinclair, M. Alkattan, J. Prunet and M. P. Shaver, Polym. Chem., 2017, 8, 3385–3398 RSC .
  89. A. Saura-Sanmartin, Chem.–Eur. J., 2024, 30, e202304025 CrossRef CAS PubMed .
  90. S. Kang, M. M. Cetin, R. Jiang, E. S. Clevenger and M. F. Mayer, J. Am. Chem. Soc., 2014, 136, 12588–12591 CrossRef CAS PubMed .
  91. H. W. Gibson, S. H. Lee, P. T. Engen, P. Lecavalier, J. Sze, Y. X. Shen and M. Bheda, J. Org. Chem., 1993, 58, 3748–3756 CrossRef CAS .
  92. P. R. Ashton, D. Philp, N. Spencer and J. F. Stoddart, J. Chem. Soc. Chem. Commun., 1992, 1124–1128,  10.1039/C39920001124 .
  93. Z. E. Wilson, A. M. Heapy and M. A. Brimble, Tetrahedron, 2007, 63, 5379–5385 CrossRef CAS .
  94. Y. Kobayashi and H. Okui, J. Org. Chem., 2000, 65, 612–615 CrossRef CAS PubMed .
  95. W. Zhong, Y. Tang, G. Zampella, X. Wang, X. Yang, B. Hu, J. Wang, Z. Xiao, Z. Wie, H. Chen, L. De Gioia and X. Liu, Inorg. Chem. Commun., 2010, 13, 1089–1092 CrossRef CAS .
  96. M. Li and G. A. O'Doherty, Org. Lett., 2006, 8, 3987–3990 CrossRef CAS PubMed .
  97. L. A. Ortiz-Frade, L. Ruiz-Ramírez, I. González, A. Marín-Becerra, M. Alcarazo, J. G. Alvarado-Rodriguez and R. Moreno-Esparza, Inorg. Chem., 2003, 42, 1825–1834 CrossRef CAS PubMed .
  98. P. Schwab, R. H. Grubbs and J. W. Ziller, J. Am. Chem. Soc., 1996, 118, 100–110 CrossRef CAS .
  99. (a) CCDC 967317: Experimental Crystal Structure Determination, 2025,  DOI:10.5517/ccdc.csd.cc11gksv ; (b) CCDC 2469972: Experimental Crystal Structure Determination, 2025,  DOI:10.5517/ccdc.csd.cc2nx6jb .

Footnote

Crystal data for polymorph 1 of complex 7: C62H58CuF6N4O8P, M = 1195.63, triclinic, P[1 with combining macron], a = 14.7809(14), b = 14.8375(16), c = 15.4905(18) Å, α = 115.129(11), β = 114.546(10), γ = 92.324(8)°, V = 2698.9(6) Å3, Z = 2, T = 173(2) K, 6604 unique reflections. Refinement of 801 parameters converged at final R1 [I > 2σ(I)] of 0.0754, wR2 (all data) of 0.1548. Crystal data for polymorph 2: C62H58CuF6N4O8P, M = 1195.63, monoclinic, P21/c, a = 16.7265(8), b = 7.8498(4), c = 43.035(2) Å, β = 96.345(5)°, V = 5615.8(5) Å3, Z = 4, T = 173(2) K, 6867 unique reflections. Refinement of 834 parameters converged at final R1 [I > 2σ(I)] of 0.1472, wR2 (all data) of 0.3205. See Table S1 in the SI for more details.

This journal is © The Royal Society of Chemistry 2025
Click here to see how this site uses Cookies. View our privacy policy here.